Navigation Links
Brain study may lead to improved epilepsy treatments
Date:4/14/2008

Using a rodent model of epilepsy, researchers found one of the bodys own neurotransmitters released during seizures, glutamate, turns on a signaling pathway in the brain that increases production of a protein that could reduce medication entry into the brain. Researchers say this may explain why approximately 30 percent of patients with epilepsy do not respond to antiepileptic medications. The study, conducted by researchers at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, and the University of Minnesota College of Pharmacy and Medical School, in collaboration with Heidrun Potschkas laboratory at Ludwig-Maximilians-University in Munich, Germany, is available online and will appear in the May 2008, issue of Molecular Pharmacology.

Our work identifies the mechanism by which seizures increase production of a drug transport protein in the blood brain barrier, known as P-glycoprotein, and suggests new therapeutic targets that could reduce resistance, said David Miller, Ph.D., a principal investigator in the NIEHS Laboratory of Pharmacology and co-author on the paper.

The blood-brain barrier (BBB), which resides in brain capillaries, is a limiting factor in treatment of many central nervous system disorders. It is altered in epilepsy so that it no longer permits free passage of administered antiepileptic drugs into the brain. Miller explained that P-glycoprotein forms a functional barrier in the BBB that protects the brain by limiting access of foreign chemicals.

The problem is that the protein does not distinguish well between neurotoxicants and therapeutic drugs, so it can often be an obstacle to the treatment of a number of diseases, including brain cancer, Miller said. Increased levels of P-glycoprotein in the BBB has been suggested as one probable cause of drug resistance in epilepsy.

Using isolated brain capillaries from mice and rats and an animal model o
'/>"/>

Contact: Robin Mackar
rmackar@niehs.nih.gov
919-541-0073
NIH/National Institute of Environmental Health Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. Invasion of the brain tumors
2. HIV is a double hit to the brain
3. AIDS interferes with stem cells in the brain
4. 60 second test could help early diagnosis of common brain diseases
5. U of MN researchers discover noninvasive diagnostic tool for brain diseases
6. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
7. Influence of sex and handedness on brain is similar in capuchin monkeys and humans
8. Inside the brain of a crayfish
9. Specific brain protein required for nerve cell connections to form and function
10. Brains timing linked with timescales of the natural visual world
11. Adult brain can change, study confirms

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...g the total gene activity in organs relevant for c...edish medical university Karolinska Institutet hav...or the recruitment of white blood cells into the a...be published in the open-access journal PLoS Gene...te blood cells in the development of atheroscleros...
(Date:12/4/2009)...se is available in German . , A new study of ...ld help to understand the positive effect of dieta...e from different organisms (fruit flies and mice) ...evity, but with a potential negative side effect o...produces less frequently with a reduced litter siz...
(Date:12/3/2009)... WALL, N.J., Dec. 3 BIO-..., a leader in wireless public safety and finger-ba...that a majority of its shareholders at a Special S... the company,s Law Enforcement Division to Interac...% were cast in favor and 1.2% were opposed. ,, ...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2How nutrition affects healthy aging 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Vermillion Announces Return of Eric Fung M D Ph D 14338 1Vermillion Announces Return of Eric Fung M D Ph D 14338 2Vermillion Announces Return of Eric Fung M D Ph D 14338 3Cantel Medical Corp To Hold Conference Call To Discuss Fourth Quarter and Fiscal 2009 Results 5196 1Cantel Medical Corp To Hold Conference Call To Discuss Fourth Quarter and Fiscal 2009 Results 5196 2ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2009 Financial Results 5193 1
...elease is available in French . , Montreal, May...leted a massive survey of the network of protein c...s of life. In the online edition of the journal Sc...escribe protein complexes and networks of complexe...in the normal mechanisms by which cells divide and...
...helle, NY, May 13, 2008Gene therapy to replace the...e disease that is fatal by age 8-12 years, was abl...line in treated children, according to a paper pub... (Vol. 19 No. 5) of Human Gene Therapy, a peer-rev...The paper is available free online at www.liebertp...
... (May 13, 2008) Lunar dust could be more than a ...on. Their good health may depend on the amount of ...epare for a return to the moon, researchers with t...SBRI) are evaluating how dust deposits in the lung... risk of long-term exposure to the particles. The ...
Other Biology News:Researchers discover architecture for fundamental processes of life 2Gene therapy slows progression of fatal neurodegenerative disease in children 2Astronaut health on moon may depend on good dusting 2
(Date:12/2/2009)... , , CAMBRIDGE, Mass., Dec. 2 /PRNe...gether the leaders in technology development and p... and MEMS, announced the December 11th deadline fo... ,, Now in its 14th year, TechConnect World, in...Institute (NSTI), and the Clean Technology and Sus...
(Date:12/2/2009)... , , RESTON, Va., Dec. 2 /PRNewswi...d Dairy" or the "Company") (OTC Bulletin Board: EM...and children,s formula, milk powder and,soybean pr...will be featured,in the Spring issue of US Food &a...eadership of over 250,000 executives in the food a...
(Date:12/2/2009)... , , SHANGHAI, Dec. 2 /PRNewswire-...times; markets are in turmoil and uncertainty is p...t that the pharma industry has been,relatively imm...n,t take a,vacation. , During the midst o...l,giant Johnson & Johnson inaugurated an R&...
(Date:12/1/2009)... , Dr. Kerry Solomon anno...ns and has launched his redesigned website at www...al Consulting Group. Dr. Solomon is a proven LASI...as been professionally recognized for his substant...urgery. He is a member of Trusted LASIK Surgeons,...
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
...ntrols Inc. (OTCBB: FOUR.OB) today announced it ha...r. Philip Hayden as its Vice President, Security A... NEW YORK (Business Wire EON) August 18... distinguished career with the Federal Bureau of I...volved in many aspects of law enforcement and secu...
...on in Upfront Fees and Milestones -, DALLAS, Aug....ard: ACCP) and Milestone Biosciences, LLC ("Milest...license agreement under which,Milestone will marke...ited,States and Canada. Milestone is a company rec...sentatives of companies with an established,commer...
... China, Aug. 18 /PRNewswire-FirstCall/,-- MicuRx P...utical company,developing next-generation antibiot...ts first preclinical development candidate. MRX-I ...resistant gram-positive,bacteria, including methic...ltaneously, the company expanded its operations in...
Other Biology Technology: 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 2 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 3 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 4Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America 2Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America 3MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China 2
Mouse Anti-Lamin B1, B2 Monoclonal Antibody, Unconjugated, Clone X223 from Abcam
Rabbit Anti-TAB1 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-FANCE Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human FANCG Polyclonal Antibody, Unconjugated from Abcam
Biology Products: